ChampionRHRobertsSOBCarpenterRG. Urticaria and angioedema. Br J Dermatol1969; 81:588.
2.
GreavesMW. Chronic urticaria. N Engl J Med1995; 332: 1767–1772.
3.
NizamiRMBabooMT. Office management of patients with urticaria: An analysis of 215 patients. Ann Allergy1974; 33:78–85.
4.
CooperRHRobertsSOCarpenterRGRogerJH. Urticaria and angioedema: Diagnosis and evaluation. J Am Acad Dermatol1991; 25:166–176.
5.
MonroeEWJonesHE. Urticaria: An updated review. Arch Dermatol1977; 113:80–90.
6.
NicholsAW. Exercise-induced and urticaria. Clin Sports Med1992; 11:303–312.
7.
BreathnachSMAllenRWardAMGreavesMW. Symptomatic dermographism: Natural history, clinical features laboratory investigations, and response to therapy. Clin Exp Dermatol1983; 8:463–476.
8.
KaplanAPBeavenMA. In vivo studies of the pathogenesis of cold urticaria, cholinergic urticaria, and vibration-induced swelling. J Invest Dermatol1976; 67:327–332.
9.
BarlowRJWarburtonFWatsonK. Diagnosis and incidence of delayed pressure urticaria in patients with chronic urticaria. J Am Acad Dermatol1993; 29:954–958.
10.
LawlorFBlackAKWardAM. Delayed pressure urticaria, objective evaluation of a variable disease using a dermographometer and assessment of treatment using colchicine. Br J Dermatol1989; 120:403–408.
11.
WillisIEpsteinJH. Solar- vs heat-induced urticaria. Arch Dermatol1979; 110:389–392.
12.
CommensCAGreavesMW. Tests to establish the diagnosis in cholinergic urticaria. Br J Dermatol1978; 98:47–51.
13.
SevumRJ. Urticaria. The diagnostic challenge of hives. Postgrad Med1996; 100:77–84.
14.
KanwarAJGreavesMW. Approach to the patient with chronic urticaria. Hosp Pract (Off Ed)1996; 31:175–189.
15.
FoxRW. Update on urticaria and angioedema. Allergy Proc1995; 16:289–292.
16.
JuhlinL. Localization and content of histamine in normal and diseased skin. Acta Derm Venereol (Stockh)1967; 47:383–391.
17.
KaplanAPHorakovaZKatzS. Assessment of tissue fluid histamine levels in patients with urticaria. J Allergy Clin Immunol1978; 61:350–354.
BedardPMBrunetCPelletierGHebertJ. Increased compound 48/80-induced local histamine release from nonlesional skin of patients with chronic urticaria. J Allergy Clin Immunol1986; 78:1121–1125.
20.
SabroeRAGreavesMW. The pathogenesis of chronic idiopathic urticaria. Arch Dermatol1997; 133:1003–1008.
21.
HideMFrancisDMGrattanCE. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med1993; 328:1599–1604.
22.
MalaviyaRMorrisonARPentlandAP. Histamine in human epidermal cells is induced by ultraviolet light injury. J Invest Dermatol1996; 106:785–789.
23.
NawataYKoikeTHosokawaH. Anti-IgE autoantibody in patients with atopic dermatitis. J Immunol1985; 135:478–482.
24.
MaroneGCasolaroVPagenelliRQuintiI. IgG anti-IgE from atopic dermatitis induces mediator release from basophils and mast cells. J Invest Dermatol1989; 93:246–252.
25.
MichaelssonGHuhlinL. Urticaria induced by preservatives and dye additives in food and drugs. Br J Dermatol1978; 88:525–532.
26.
LeahachJGRosenstreichDL. Clinical aspects of chronic urticaria. Clin Rev Allergy1992; 10:281–301.
27.
GoodmanDLMcDonnellJTNelsonHS. Chronic urticaria exacerbated by antioxidant food preservatives, butylated hydroxy-anisole (BHA) and butylated hydroxytoluene (BHT). J Allergy Clin Immunol1990; 86:570–575.
28.
WarinRP. The effect of aspirin in chronic urticaria. Br J Dermatol1960; 72:350–351.
29.
WearyPEGuerrantJL. Chronic urticaria in association with dermatophytosis. Response to administration of griseofulvin. Arch Dermatol1967; 95:400–401.
30.
Platts-MillsTAFioccoGPHaydenML. Serum IgE antibodies to Trichophyton in patients with urticaria, angioedema, asthma, and rhinitis: Development of a radioallergosorbent test. J Allergy Clin Immunol1987; 79:40–45.
31.
CondemiJJ. Update in allergy and immunology. Ann Intern Med1996; 125:744–750.
32.
SoterNA. Acute and chronic urticaria and angioedema. J Am Acad Dermatol1991; 25:146–154.
33.
O'DonnellBFBarlowRJBlackA KobzaGreavesMW. Response of severe chronic urticaria to intravenous immunoglobulin (IVIG). Br J Dermatol1994; 181(Suppl 44):23.
34.
GrattanCEHFrancisDMSlaterNGP. Plasmapheresis for severe, unremitting, chronic urticaria. Lancet1992; 339: 1078–1080.
35.
RumbyrtJSKatzJLSchocketAL. Resolution of chronic urticaria in patients with thyroid autoimmunity. J Allergy Clin Immunol1995; 96:901–905.
36.
O'DonnellBFSwanaGTKobzaAGreavesMW. Organ and non-organ specific auto-immunity in chronic urticaria. Br J Dermatol1995; 133(Suppl45):42.
37.
LeznoffASussmanGL. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: A study of 90 patients. J Allergy Clin Immunol1989; 84:66–71.
38.
CharlesworthEN. Urticaria and angioedema: A clinical spectrum. Ann Allergy Asthma Immunol1996; 76:484–496.
39.
SoterNAFitzpatrickTSEisenAZ. Urticaria and angioedema. In: FitzpatrickTBEisenAZ, eds. Dermatology in general medicine. 4th Ed.New York: McGraw Hill, 1993: 1483–1493.
JonesRRBhogalBDashASchifferliJ. Urticaria and vasculitis: A continuum of histological and immunopathological changes. Br J Dermatol1983; 108:695–703.
42.
MonroeWE. The role of antihistamines in the treatment of chronic urticaria. J Allergy Clin Immunol1990; 86:662–665.
43.
BlackAK. H1 antagonists in the management of the itch of urticarias. Skin Pharmacol1992; 5:21–24.
44.
MonroeEW. Chronic urticaria: A review of nonsedating H1 antihistamines in treatment. J Am Acad Dermatol1988; 19:842–849.
45.
JuhlinLLandorM. Drug therapy for chronic urticaria. Clin Rev Allergy1992; 10:349–369.
46.
MonroeEW. Nonsedating H1 antihistamines in chronic urticaria. Ann Allergy1993; 71:585–591.
47.
GoldsmithPDowdPM. The new H1 antihistamines. Treatment of urticaria and other clinical problems. Dermatol Clin1993; 11:87–95.
48.
GreenSLReedCESchroeterAL. Double-blind cross-over study comparing doxepin with diphenhydramine for the treatment of chronic urticaria. J Am Acad Dermatol1985; 12: 669–674.
49.
HarveyRPWegsJSchocketAL. A controlled trial of therapy in chronic urticaria. J Allergy Clin Immunol1981; 68: 262–266.
50.
CommensCAGreavesMW. Cimetidine in chronic idiopathic urticaria: A randomized double-blind study. Br J Dermatol1978; 99:675–679.
51.
BriggsGGFreemanRKYaffeSJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 2nd Ed.Baltimore: Williams and Wilkins, 1986:84, 385.
52.
SchatzMHoffmanCPZeigerRS. The course and management of asthma and allergic diseases during pregnancy. In: MiddletonEJrReedCEEllisEF, eds. Allergy: Principle and practice. 4th Ed.Vol. 2. St. Louis, MO: Mosby-Year Book, 1993:1301–1342.
53.
SchatzMZeigerRSSeltzerJH. The safety of asthma and allergy medication during pregnancy. J Allergy Clin Immunol1997; 100:301–306.
54.
EinarsonABaileyBJungG. Prospective controlled study of hydroxyzine and cetirizine in pregnancy. Ann Allergy Asthma Immunol1997; 78:183–186.
55.
OrmerodAD. Urticaria. Recognition, causes and treatment. Drugs1994; 48:717–730.
56.
CrapsLPNeyUM. Ketotifen: Current views on its mechanism of action and their therapeutic implications. Respiration1984; 45:411–421.
57.
ChuTJWarrenMS. Zafirlukast in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol1998; 101(pt 2): Absts 641.
58.
BresslerRBSowellKHustonDP. Therapy of chronic idiopathic urticaria with nifedipine: Demonstration of beneficial effect in a double-blinded, placebo-controlled, crossover. J Allergy Clin Immunol1989; 83:756–763.
59.
MonroeEW. Chronic urticaria: Review of drug management. In: ChampionRHGreavesMWBlackA KobzaPyeRJ, eds. The urticarias. Edinburgh, Scotland: Churchill Livingstone, 1985:205–211.
60.
BrestelEPThrushLB. The treatment of glucocorticoid dependent chronic urticaria with stanazolol. J Allergy Clin Immunol1988; 82:265–269.
61.
ShelleyWBShelleyED. Acyclovir therapy for angioedema and chronic urticaria. Cutis1997; 59:85–88.